Glycaemic Control Impact on Renal Endpoints in Diabetic Patients on Haemodialysis
Objective. To identify the number of haemodialysis patients with diabetes in a large NHS Trust, their current glycaemic control, and the impact on other renal specific outcomes. Design. Retrospective, observational, cross-sectional study. Methods. Data was collected from an electronic patient manage...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | International Journal of Nephrology |
| Online Access: | http://dx.doi.org/10.1155/2015/523521 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832547275000250368 |
|---|---|
| author | Danielle Creme Kieran McCafferty |
| author_facet | Danielle Creme Kieran McCafferty |
| author_sort | Danielle Creme |
| collection | DOAJ |
| description | Objective. To identify the number of haemodialysis patients with diabetes in a large NHS Trust, their current glycaemic control, and the impact on other renal specific outcomes. Design. Retrospective, observational, cross-sectional study. Methods. Data was collected from an electronic patient management system. Glycaemic control was assessed from HbA1c results that were then further adjusted for albumin (Alb) and haemoglobin (Hb). Interdialytic weight gains were analysed from weights recorded before and after dialysis, 2 weeks before and after the most recent HbA1c date. Amputations were identified from electronic records. Results. 39% of patients had poor glycaemic control (HbA1c > 8%). Adjusted HbA1c resulted in a greater number of patients with poor control (55%). Significant correlations were found with interdialytic weight gains (P<0.02, r=0.14), predialysis sodium (P<0.0001, r=-1.9), and predialysis bicarbonate (P<0.02, r=0.12). Trends were observed with albumin and C-reactive protein. Patients with diabetes had more amputations (24 versus 2). Conclusion. Large number of diabetic patients on haemdialysis have poor glycaemic control. This may lead to higher interdialytic weight gains, larger sodium and bicarbonate shifts, increased number of amputations, and possibly increased inflammation and decreased nutritional status. Comprehensive guidelines and more accurate long-term tests for glycaemic control are needed. |
| format | Article |
| id | doaj-art-29058d5057ac4bcca3adcc39a981c8f5 |
| institution | Kabale University |
| issn | 2090-214X 2090-2158 |
| language | English |
| publishDate | 2015-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Nephrology |
| spelling | doaj-art-29058d5057ac4bcca3adcc39a981c8f52025-02-03T06:45:27ZengWileyInternational Journal of Nephrology2090-214X2090-21582015-01-01201510.1155/2015/523521523521Glycaemic Control Impact on Renal Endpoints in Diabetic Patients on HaemodialysisDanielle Creme0Kieran McCafferty1Royal London Hospital, Whitechapel Road, London E1 1BB, UKRoyal London Hospital, Whitechapel Road, London E1 1BB, UKObjective. To identify the number of haemodialysis patients with diabetes in a large NHS Trust, their current glycaemic control, and the impact on other renal specific outcomes. Design. Retrospective, observational, cross-sectional study. Methods. Data was collected from an electronic patient management system. Glycaemic control was assessed from HbA1c results that were then further adjusted for albumin (Alb) and haemoglobin (Hb). Interdialytic weight gains were analysed from weights recorded before and after dialysis, 2 weeks before and after the most recent HbA1c date. Amputations were identified from electronic records. Results. 39% of patients had poor glycaemic control (HbA1c > 8%). Adjusted HbA1c resulted in a greater number of patients with poor control (55%). Significant correlations were found with interdialytic weight gains (P<0.02, r=0.14), predialysis sodium (P<0.0001, r=-1.9), and predialysis bicarbonate (P<0.02, r=0.12). Trends were observed with albumin and C-reactive protein. Patients with diabetes had more amputations (24 versus 2). Conclusion. Large number of diabetic patients on haemdialysis have poor glycaemic control. This may lead to higher interdialytic weight gains, larger sodium and bicarbonate shifts, increased number of amputations, and possibly increased inflammation and decreased nutritional status. Comprehensive guidelines and more accurate long-term tests for glycaemic control are needed.http://dx.doi.org/10.1155/2015/523521 |
| spellingShingle | Danielle Creme Kieran McCafferty Glycaemic Control Impact on Renal Endpoints in Diabetic Patients on Haemodialysis International Journal of Nephrology |
| title | Glycaemic Control Impact on Renal Endpoints in Diabetic Patients on Haemodialysis |
| title_full | Glycaemic Control Impact on Renal Endpoints in Diabetic Patients on Haemodialysis |
| title_fullStr | Glycaemic Control Impact on Renal Endpoints in Diabetic Patients on Haemodialysis |
| title_full_unstemmed | Glycaemic Control Impact on Renal Endpoints in Diabetic Patients on Haemodialysis |
| title_short | Glycaemic Control Impact on Renal Endpoints in Diabetic Patients on Haemodialysis |
| title_sort | glycaemic control impact on renal endpoints in diabetic patients on haemodialysis |
| url | http://dx.doi.org/10.1155/2015/523521 |
| work_keys_str_mv | AT daniellecreme glycaemiccontrolimpactonrenalendpointsindiabeticpatientsonhaemodialysis AT kieranmccafferty glycaemiccontrolimpactonrenalendpointsindiabeticpatientsonhaemodialysis |